Grifols (GRFS) Finished Goods (2016 - 2025)
Grifols' (GRFS) quarterly Finished Goods came in at $1.0 billion in Q4 2025, down 11.33% YoY from $1.1 billion in Q4 2024, and down 11.33% on a QoQ basis from $1.1 billion in Q4 2024.
Grifols (GRFS) Finished Goods (2016 - 2025) Analysis & Trends
Grifols (GRFS) has 10 years of Finished Goods data on file, last reported at $1.0 billion in Q4 2025.
- Quarterly Finished Goods fell 11.33% year-over-year to $1.0 billion in Q4 2025, while the trailing twelve-month figure through Dec 2025 was $1.0 billion (down 11.33% YoY) and the FY2025 annual result came in at $1.0 billion, down 11.33% from the prior year.
- Finished Goods retreated to $1.0 billion in Q4 2025, from $1.1 billion in the prior quarter.
- In the past five years, Finished Goods ranged from a high of $1.1 billion in Q4 2024 to a low of $679.5 million in Q4 2022.
- A 5-year average of $950.8 million and a median of $1.0 billion in 2025 frame the typical range for Finished Goods.
- Annual changes were most pronounced in 2022 — Finished Goods declined 20.09% — and 2023, when it soared 60.26%.
- Tracing GRFS's Finished Goods over 5 years: stood at $850.3 million in 2021, then slipped by 20.09% to $679.5 million in 2022, then soared by 60.26% to $1.1 billion in 2023, then increased by 3.92% to $1.1 billion in 2024, then dropped by 11.33% to $1.0 billion in 2025.
- The last three Finished Goods figures came in at $1.0 billion (Q4 2025), $1.1 billion (Q4 2024), and $1.1 billion (Q4 2023), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Johnson & Johnson | 652.20 Bn | 631.44 Bn | 17.26 Bn |
| 2 | AbbVie | 469.51 Bn | 462.94 Bn | 12.70 Bn |
| 3 | Merck | 376.81 Bn | 369.67 Bn | 12.21 Bn |
| 4 | Novartis Ag | 303.04 Bn | 295.35 Bn | 11.24 Bn |
| 5 | Astrazeneca | 257.61 Bn | 252.71 Bn | 12.86 Bn |
| 6 | Amgen | 237.37 Bn | 223.38 Bn | 7.24 Bn |
| 7 | Gilead Sciences | 181.73 Bn | 178.55 Bn | 6.22 Bn |
| 8 | Pfizer | 159.66 Bn | 147.96 Bn | 10.94 Bn |
| 9 | Gsk | 106.24 Bn | 102.07 Bn | 8.24 Bn |
| 10 | Grifols | 5.45 Bn | 4.45 Bn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 1.00 Bn |
| Dec 31, 2024 | 1.13 Bn |
| Dec 31, 2023 | 1.09 Bn |
| Dec 31, 2022 | 679.51 Mn |
| Dec 31, 2021 | 850.34 Mn |
| Dec 31, 2020 | 708.36 Mn |
| Dec 31, 2019 | 570.63 Mn |
| Dec 31, 2018 | 500.67 Mn |
| Dec 31, 2017 | 561.99 Mn |
| Dec 31, 2016 | 506.45 Mn |